Canada vs United Arab Emirates: Share of people with HIV who receive antiretroviral therapy
Canada
76.0%
in 2022
United Arab Emirates
77.0%
in 2024
Canada rank
61st
United Arab Emirates rank
59th
Share of people with HIV who receive antiretroviral therapy over time
- Canada
- United Arab Emirates
How they compare
United Arab Emirates currently reports 77.0% against 76.0% in Canada, a difference of 1.0%.
The two have swapped places 3 times across 23 shared years of data; in 2000 it was Canada ahead.
Canada ranks 61st and United Arab Emirates ranks 59th of 143 countries.
Canada has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Canada | United Arab Emirates | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 30.7% | 19.0% | 11.7% | Canada |
| 2010s | 64.2% | 27.1% | 37.1% | Canada |
| 2020s | 77.7% | 71.0% | 6.7% | Canada |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher share of people with hiv who receive antiretroviral therapy, Canada or United Arab Emirates?
- United Arab Emirates, at 77.0% against 76.0% in Canada as of 2024.
- What is the difference in share of people with hiv who receive antiretroviral therapy between Canada and United Arab Emirates?
- 1.0%, with United Arab Emirates ahead.
- How many years of comparable data are there for Canada and United Arab Emirates?
- 23 years are reported by both, from 2000 to 2022.
- How do Canada and United Arab Emirates rank globally for share of people with hiv who receive antiretroviral therapy?
- Canada ranks 61st and United Arab Emirates ranks 59th of 143 countries.
- Where does this data come from?
- UNAIDS estimates, via World Bank (2026) – processed by Our World in Data, published as Share of people with HIV who receive antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Antiretroviral therapy is a combination of several antiretroviral medicines, used to slow the rate at which HIV multiplies inside the body.